<DOC>
	<DOCNO>NCT00371059</DOCNO>
	<brief_summary>We plan evaluate use memantine Alzheimer 's disease control agitation acute situation i.e 12 week</brief_summary>
	<brief_title>Memantine Agitation Dementia</brief_title>
	<detailed_description>Agitation cause morbidity mortality Alzheimer 's due distress use medication side effect . Memantine be show associated less agitation recent study forrest pharmaceutical fail recruit . We perform 12 week rct 164 patient test hypothesis locality compete study clinical set drug often use . We compare placebo also use rescue protocol derive international best practice .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>1 . Residential/Inpatients recruitment study history least 2 week behavioural disturbance . 2 . Alzheimer 's Disease per McKhann Criteria + Hachinski Score &lt; =4 . 3 . Moderately severe severe Alzheimer 's Disease ( baseline MMSE &lt; /=19 ) . 4 . Clinically significant agitation require treatment . 5 . Severity agitation define Cohen Mansfield agitation inventory ( CMAI ) &gt; /=45 . 6 . Age &gt; /= 55 . 1 . Memantine usage 4 week prior start study . 2 . On Cholinesterase inhibitor le 3 month stable dose . 3 . Antipsychotic , antiepileptic , antidepressant , benzodiazepine , lithium hypnotic dosage alteration 2 week prior start study . 4 . Antiparkinsonian medication . 5 . Hypersensitivity memantine excipients formulation . 6 . Severe renal impairment . 7 . Epilepsy , history convulsion seizure , receive antiepileptic treatment . 8 . Concomitant usage NmethylDaspartate ( NMDA ) antagonists amantadine , ketamine dextromethorphan . 9 . Recent myocardial infarction , uncompensated congestive heart failure uncontrolled hypertension . 10 . Severe , unstable poorly control medical illness . 11 . Any disability may interfere patient complete study procedure . 12 . Active malignancy . 13 . Delirium , pain medical illness clear cause agitation . 14 . Any important drug interaction : Prohibited study 14 day precede enrollment/inclusion : Analgesic dextromethorphan , Dopaminergics amantadine , Warfarin due theoretical INR prolongation .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Agitation</keyword>
	<keyword>Dementia</keyword>
	<keyword>Alzheimer 's</keyword>
</DOC>